Methods for treating cancer resistant to ErbB therapeutics Grant US-11008620-B2 United States of America 18 May 2021
Antineoplastic combinations with mTOR inhibitor, trastuzumab and/or HKI-272 Grant US-10729672-B2 United States of America 04 Aug 2020
Method for treating gefitinib resistant cancer Grant US-10603314-B2 United States of America 31 Mar 2020
Method for treating gefitinib resistant cancer Grant US-10596162-B2 United States of America 24 Mar 2020